In conclusion, the relationship between vitamin D blood levels and the development of arthralgia in women with breast cancer under aromatase inhibitor treatment remains unclear, as well as the potential use of vitamin D supplementation to reduce this side effect. Here, CYP19A1 is linked to breast carcinoma.